ceric oxide has been researched along with Liver Steatosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carvajal, S; Casals, E; Casals, G; Fernández-Varo, G; González de la Presa, B; Jiménez, W; Oró, D; Puntes, V; Reichenbach, V; Sandalinas, S; Yudina, T | 1 |
1 other study(ies) available for ceric oxide and Liver Steatosis
| Article | Year |
|---|---|
Cerium oxide nanoparticles reduce steatosis, portal hypertension and display anti-inflammatory properties in rats with liver fibrosis.
Topics: Actins; Animals; Anti-Inflammatory Agents; Apoptosis; Caspase 3; Cerium; Endoplasmic Reticulum Stress; Fatty Liver; Hypertension, Portal; Liver; Liver Cirrhosis; Nanoparticles; Rats; Reactive Oxygen Species | 2016 |